Diaceutics (LSE:DXRX) Cash Flow for Dividends: £0.00 Mil (TTM As of Dec. 2025)


LSE:DXRX Diaceutics PLC LSE:DXRX
92 GF Score
Price £1.45
GF Value £1.91
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Diaceutics Cash Flow for Dividends?

Diaceutics LSE:DXRX -0.34% 92 Cash Flow for Dividends is £0.00 Mil as of Dec. 2025. GuruFocus rates LSE:DXRX with a GF Score™ of 92/100 and a GF Value™ of £1.91 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Diaceutics's cash flow for dividends for the six months ended in Dec. 2025 was £0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was £0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Diaceutics Cash Flow for Dividends Related Terms

Diaceutics Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Diaceutics's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diaceutics Cash Flow for Dividends Chart

Diaceutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Diaceutics Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LSE:DXRX
92GF Score
Diaceutics PLC LSE:DXRX
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diaceutics Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of £0.00 Mil mean?
Diaceutics (LSE:DXRX) has a Cash Flow for Dividends of £0.00 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Diaceutics and its competitors.
Is Diaceutics' Cash Flow for Dividends too high?
Diaceutics' current Cash Flow for Dividends is £0.00 Mil. Overall, Diaceutics has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Diaceutics' Cash Flow for Dividends compare to VEEV and BTSG?
Diaceutics' Cash Flow for Dividends of £0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Healthcare Providers & Services company?
A good Cash Flow for Dividends depends on the Healthcare Providers & Services industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Diaceutics and its competitors. Diaceutics's current Cash Flow for Dividends is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diaceutics stock overvalued right now?
Based on GuruFocus' analysis, Diaceutics (LSE:DXRX) is currently considered Modestly Undervalued. The stock's GF Value™ is £1.91, compared to a current price of £1.45 — trading 24.3% below its estimated fair value. The current Cash Flow for Dividends is £0.00 Mil. Diaceutics' overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Diaceutics (LSE:DXRX), the current Cash Flow for Dividends is £0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diaceutics (LSE:DXRX) Overvalued in 2026?

Based on GuruFocus' analysis, Diaceutics stock appears to be undervalued. The current stock price of £1.45 is trading 24.3% below its estimated GF Value™ of £1.91. GuruFocus considers Diaceutics to be Modestly Undervalued.

Key valuation signals for LSE:DXRX:

  • Cash Flow for Dividends: £0.00 Mil
  • GF Value™: £1.91 vs. price of £1.45 (24.3% below fair value)
  • GF Score™: 92/100 with 1 warning sign

No single metric tells the full story. See the LSE:DXRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diaceutics Business Description

Other Exchanges DIUXF:USA7DC:Germany
Address Dataworks at Kings Hall Health & Wellbeing Park, First Floor, Building Two, County Antrim, Belfast, GBR, BT9 6GW
Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides integrated commercialization solutions that help biopharma companies maximize patient access, accelerate uptake, and improve the lifetime value of their therapies. The group's services span the full commercial lifecycle, from pre-launch ideas through to mature brand optimization, delivered through an integrated combination of data, technology, and expertise. Its DXRX Data Solutions include DXRX Signal, DXRX Physician Segmentation, DXRX Lab Segmentation, and DXRX Disease Testing Rate Tracker. Geographical market by customer location in the UK, North America, Europe, Asia, and the rest of the world.
92GF Score

Get the complete analysis for LSE:DXRX

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£1.45
Price
£1.91
GF Value